VEGFA and prostate cancer: As for cancer types, there are 4 studies on VEGF-460 and gastric cancer susceptibility, 7 on breast cancer, 4 on prostate cancer, 3 on oral cancer, 3 on colorectal cancer, 2 on colon cancer, 2 on glioma, 3 on cervical cancer, 2 on ovarian cancer, 2 on bladder cancer, 5 on hepatocellular carcinoma, 11 on lung cancer, and 5 on renal cell carcinoma, in addition to studies on endometrial cancer, esophageal adenocarcinoma, pancreatic cancer, nasopharyngeal cancer, osteosarcoma, thyroid cancer, and cutaneous squamous cell carcinoma.